Cargando…

From Diabetes Care to Heart Failure Management: A Potential Therapeutic Approach Combining SGLT2 Inhibitors and Plant Extracts

Diabetes is a complex chronic disease, and among the affected patients, cardiovascular disease (CVD)is the most common cause of death. Consequently, the evidence for the cardiovascular benefit of glycaemic control may reduce long-term CVD rates. Over the years, multiple pharmacological approaches ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Gliozzi, Micaela, Macrì, Roberta, Coppoletta, Anna Rita, Musolino, Vincenzo, Carresi, Cristina, Scicchitano, Miriam, Bosco, Francesca, Guarnieri, Lorenza, Cardamone, Antonio, Ruga, Stefano, Scarano, Federica, Nucera, Saverio, Mollace, Rocco, Bava, Irene, Caminiti, Rosamaria, Serra, Maria, Maiuolo, Jessica, Palma, Ernesto, Mollace, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504067/
https://www.ncbi.nlm.nih.gov/pubmed/36145112
http://dx.doi.org/10.3390/nu14183737
Descripción
Sumario:Diabetes is a complex chronic disease, and among the affected patients, cardiovascular disease (CVD)is the most common cause of death. Consequently, the evidence for the cardiovascular benefit of glycaemic control may reduce long-term CVD rates. Over the years, multiple pharmacological approaches aimed at controlling blood glucose levels were unable to significantly reduce diabetes-related cardiovascular events. In this view, a therapeutic strategy combining SGLT2 inhibitors and plant extracts might represent a promising solution. Indeed, countering the main cardiometabolic risk factor using plant extracts could potentiate the cardioprotective action of SGLT2 inhibitors. This review highlights the main molecular mechanisms underlying these beneficial effects that could contribute to the better management of diabetic patients.